The FINANCIAL -- Merck known as MSD outside the United States and Canada, today announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Merck acquired MK-7110 through the acquisition of OncoImmune, a privately held, clinical-stage biopharmaceutical company.…
Read More »
The FINANCIAL -- Merck known as MSD outside the United States and Canada, today announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and…
You might be interested in
In 2017, Ninja Theory, advised by Cambridge academic Professor Paul Fletcher, took the gaming world by storm with Hellblade, which…
The FINANCIAL — It is often believed that a close relationship between owners and their dogs can bring many mental health…
The FINANCIAL — Blood pressure should be measured in both arms and the higher reading should be adopted to improve hypertension…
Discovery sets the stage for development of new therapies to treat vitelliform macular dystrophy. Using a new imaging technique, researchers…